Systematic review and meta-analysis of 30 studies (269 patients) of centromedian thalamic DBS for drug-resistant epilepsy: median seizure reduction 71.5%, 74.6% responders, likely an upper bound given high risk of bias. No single stimulation parameter robustly predicted outcome.
Meta-analysisn = 269
AlQahtani et al. Programming of deep brain stimulation of the centromedian nucleus of the thalamus for drug-resistant epilepsy: A meta-analysis and proposed programming framework